ArticlePsychiatry research2022
Long-COVID and comorbid depression and anxiety two years into the COVID-19 pandemic.
Article in Psychiatry research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Symptoms of Depression and Anxiety After COVID-19 Despite Systematic Telemedical Care: Results From the Prospective COVID-SMART Study.Depression and anxiety · 2025Trial
- Analysis of epidemiological characteristics and influencing factors of Long COVID syndrome among university students in the post-pandemic era.Frontiers in public health · 2026Article
- Disentangling Heterogeneity in the Co-Developmental of Anxiety and Depression During the COVID-19 Pandemic: Insights From Cross-Lagged Panel Network.Depression and anxiety · 2026Article
- Long COVID and psychosocial factors among middle-aged and older adults. Results of the nationally representative German Ageing Survey.Aging clinical and experimental research · 2025Article
- First episode of psychiatric and neuropsychiatric disease among patients infected with COVID-19: A scoping review.PCN reports : psychiatry and clinical neurosciences · 2025Review
- Short and long-term trajectories of the post COVID-19 condition: Results from the EuCARE POSTCOVID study.BMC infectious diseases · 2025Article
- A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States.Communications medicine · 2025Article
- Mental Health in the Time of the COVID-19 Pandemic: A Scoping Review of Collateral Effects on Common Mental Disorders (CMDs).International journal of environmental research and public health · 2025Article
- Health Resort Treatment Mitigates Neuropsychiatric Symptoms in Long COVID Patients: A Retrospective Study.Healthcare (Basel, Switzerland) · 2025Article
- Photobiomodulation: shining a light on depression.Theranostics · 2025Review
- Evaluating the longitudinal physical and psychological health effects of persistent long Covid 3.5 years after infection.PloS one · 2025Observational
- Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in Long COVID.Frontiers in immunology · 2025Article
- Anxiety and Depressive Symptoms Among Kidney Transplant Recipients in Post-COVID-19 China: Prevalence and Risk Factors.Risk management and healthcare policy · 2025Article
- Depressive symptomatology in Brazil: perspectives of statistical and psychometrics analyses of the PHQ-9 at four time-points (2020-2023) in the COVID-19 pandemic.Frontiers in psychology · 2025Article
- Long-term outcomes of post-acute sequelae of SARS-CoV-2 infection: a cohort study protocol.Frontiers in public health · 2025Article
- Personality and neuropsychiatric symptoms in individuals diagnosed with long COVID.BMC infectious diseases · 2024Article
- Investigating the Associations Between COVID-19, Long COVID, and Sleep Disturbances: Cross-Sectional Study.JMIR public health and surveillance · 2024Article
- Long covid and mental and physical health: A cross-sectional study of adults in California.Public health challenges · 2024Article
- Characteristics and burden of acute COVID-19 and long-COVID: Demographic, physical, mental health, and economic perspectives.PloS one · 2024Article
- Long COVID outcomes following omicron wave in non-hospital population.Frontiers in public health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long-COVID, or the persistence of COVID-19 symptoms for months after initial infection, has been shown to impact the lives of those affected. The current study sought to investigate the relationships between long-COVID, COVID-19 related stress, depression, anxiety, and comorbid depression and anxiety outcomes. Data were collected in Winter 2021-2022 from a population of adults enrolled in at least one course across multiple City University of New York (CUNY) campuses. Frequencies and chi-square tests were computed to assess for demographics and relationships to probable diagnoses of depression and anxiety, and binary logistic regressions were computed to assess for the odds of probable comorbid depression and anxiety based on demographics, stressors, and long-COVID. Women participants reported higher odds of probable depression outcomes, and stressor levels were significant correlates of probable anxiety outcomes. Women participants, 3.2 [1.5-6.9], as compared to men, lower-SES participants, 2.16 [1.1-4.2], as compared to higher-SES participants, participants with higher COVID-19 related stress levels, 4.8 [2.0-12.0], as compared to those with low levels, and participants with long-COVID, 3.7 [1.9-7.0], as compared to those without, all had higher odds of probable comorbid depression and anxiety. Findings highlight the importance of social location, stress, and long-COVID, in tandem, as correlates of psychological health during the shifting pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.